Comparison study between quantitative evaluation using dynamic contrast enhancement MRI for assessment of tumor aggressiveness in transitional prostate cancer and gleason score of histopathological evaluation

Quantitative evaluation using dynamic contrast enhancement MRI (using TWIST-vibe) for assessment of tumor aggressiveness in transitional prostate cancer - Quantitative evaluation using DCE-MRI (using TWIST-vibe) for assessment of tumor aggressiveness in transitional prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053281

Enrollment

100

Registered

2024-01-05

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transitional prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients were over PSA 4.0ng/ml. Patients with transitional prostate cancer diagnosed by biopsy before performing dynamic contrast enhancement MRI.

Exclusion criteria

Exclusion criteria: Patients with transitional prostate cancer diagnosed by biopsy before not performing dynamic contrast enhancement MRI.

Design outcomes

Primary

Measure	Time frame
Statistical correlation between dynamic contrast-enhanced MRI quantitative analysis parameters and Gleason score of histopathological evaluation. Research period: from March 2021 to March 2023	—

Countries

Japan

Contacts

Public ContactMariko Doai

Kanazawa Medical University Department of Radiology

doaimari@kanazawa-med.ac.jp076-286-2211

Outcome results